Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · IEX Real-Time Price · USD
2.190
-0.020 (-0.90%)
At close: Apr 19, 2024, 4:00 PM
2.200
+0.010 (0.46%)
After-hours: Apr 19, 2024, 7:30 PM EDT
Immix Biopharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Immix Biopharma stock has a target of 14, which predicts an increase of 539.27% from the current stock price of 2.19.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 14, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for IMMX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +539.27% | Aug 14, 2023 |
| Roth MKM | Roth MKM | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +539.27% | Feb 22, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.95
from -0.89
EPS Next Year
-1.03
from -0.95
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 12.7M | 50.6M | 115.4M |
| Avg | n/a | n/a | 12.4M | 49.1M | 112.1M |
| Low | n/a | n/a | 11.9M | 47.2M | 107.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 308.3% | 134.9% |
| Avg | - | - | - | 296.6% | 128.2% |
| Low | - | - | - | 281.1% | 119.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.98 | -1.06 | -0.39 | 0.87 | 2.87 |
| Avg | -0.95 | -1.03 | -0.38 | 0.85 | 2.78 |
| Low | -0.91 | -0.99 | -0.36 | 0.81 | 2.68 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 238.6% |
| Avg | - | - | - | - | 228.9% |
| Low | - | - | - | - | 216.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.